Brussels, 19/05/2005 (Agence Europe) - On 19 May, one year after the definitive adoption of the directive setting quality and safety standards for human cells and tissues, the European Commission presented the new authorisation procedure for the sales of products created from cell and tissue engineering, which are increasingly used in medicine, to repair physical damage or as a medical treatment. This new centralised procedure will be managed in London by the European Medicines...